The China potential is going to be huge and could very well trigger a tremendous demand for Pediatric RapiMeds a lot sooner than in the U.S. My best guess is the imminent China trip is not an exploratory mission, but the conclusion of the hard efforts by our CEO , Mr. Schneiderman, over these last several months to secure client interest and purchase orders for Pediatric RapiMeds. And who knows, maybe even other applications of the RapiMeds technology where generic versions of medication are available without the restrictions that exists here in the U.S. These are exciting times for SCRC. With the five existing revenue streams already developed by Bob, The China potential will position SCRC as a formidable player not only in the stock market , but the generic drug market across the world, for 2014 and beyond. Between you and me, I wouldn't mind one bit if the PPS remains in the .25 to .30 range these next several weeks . It would provide us all with the opportunity to buy low and gain huge profits when the stock explodes in 2014. Let's be real, we are all in this to make money. None of us intend to hold onto SCRC forever, and I am convince 12 to 18 months from now we will all (theCORE) realize gains exceeding any of our greatest expectations. I realize there are other stocks out there where gains can be made now, but for me, I chose SCRC as my Dream to Reality stock. I have the time and patience to wait. Go SCRC!!!